Page last updated: 2024-10-23

bisbenzimidazole and Carcinoma, Epidermoid

bisbenzimidazole has been researched along with Carcinoma, Epidermoid in 2 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takashima, T1
Fujiwara, Y1
Hamaguchi, M1
Sasaki, E1
Tominaga, K1
Watanabe, T1
Oshitani, N1
Higuchi, K1
Arakawa, T1
Eynard, AR1
Jiang, WG1
Mansel, RE1

Other Studies

2 other studies available for bisbenzimidazole and Carcinoma, Epidermoid

ArticleYear
Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Oncology reports, 2005, Volume: 13, Issue:4

    Topics: Antibodies, Monoclonal; Apoptosis; Barrett Esophagus; Biopsy; Bisbenzimidazole; Blotting, Western; C

2005
Eicosatrienoic acid (20:3 n-9) inhibits the expression of E-cadherin and desmoglein in human squamous cell carcinoma in vitro.
    Prostaglandins, leukotrienes, and essential fatty acids, 1998, Volume: 59, Issue:6

    Topics: 8,11,14-Eicosatrienoic Acid; Bisbenzimidazole; Blotting, Western; Cadherins; Carcinoma, Squamous Cel

1998